Search Results
147 results
Your search is now limited to «Monoclonal Antibody Therapy» expert search.
PR Newswire 03/20/2019 19:20
Leveraging the platform, the company has built up a robust pipeline of 20 innovative assets in the fields of oncology, ophthalmology, autoimmunity, and cardiovascular diseases.
More from PR Newswire: 03/20/2019 16:45
The results have major implications for management of recurrent/advanced endometrial cancer, a condition that has limited treatment options, Ana Oaknin, MD, of Vall d'Hebron Hospital in Barcelona, said at the Society of Gynecologic Oncology meeting.
More from
Targeted Oncology 03/20/2019 13:05
In an interview with Targeted Oncology following her presentation, Casulo discussed challenges in the management of patients with relapsed/refractory FL.
More from Targeted Oncology:
GlobeNewswire 03/18/2019 06:00
In the setting of cancer, research has shown that CCR5 likely plays a central role in tumor invasion and metastasis and that increased CCR5 expression is an indicator of disease status in several cancers.
More from GlobeNewswire:
Business Wire 03/18/2019 05:00
In the field of oncology, NantCell’s goal is to employ a broad portfolio of biological molecules that will enable it to activate the endogenous NK, CD8+ T cell and develop a T cell memory cancer vaccine to combat multiple tumor types without the use of high-dose chemotherapy ...
More from Business Wire:
Additionally, the Company is leveraging its assets to develop an early-stage pipeline of multifaceted, next-generation NK cell therapies targeting hematological malignancies and solid tumors, including its RONK„¢ (Retargeted Optimized NK cell) therapy.
More from Global Banking & Finance Review:
Johnson & Johnson 03/12/2019 16:41
16] Most recently, in May 2018, DARZALEX received approval in combination with bortezomib, melphalan and prednisone for the treatment of patients with newly diagnosed multiple myeloma who are ineligible for ASCT, making it the first monoclonal antibody approved for newly diagnosed patients with this disease.
The monoclonal antibody attaches to and blocks PD-L1, a protein present on the surface of many cancer cells.
More from European Medicines Agency - EMEA:
Hoffmann-La Roche 03/11/2019 02:00
About Roche in cancer immunotherapy For more than 50 years, Roche has been developing medicines with the goal to redefine treatment in oncology.
More from Hoffmann-La Roche: 03/07/2019 09:39
Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread.
More from
This complete and sustained eradication of all CD19+ cells may lead to a more effective B cell depletion than that obtained with monoclonal antibody therapy.
More from Science Translational Medicine:

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors


Diagnostics and Therapeutics


Drugs - Brand Names

Drugs - Generic



Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices



Strategic Scenarios



On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 

  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications